Figure 2.
Progression-free survival of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy (n = 238). CL, confidence limit.
Progression-free survival of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy (n = 238). CL, confidence limit.
